The Ipr gene in homozygous form induces development of CD4 -CD8 -B220+ T cells and lymphadenopathy in MRL and C57BL/6 mice. Although the propensity for excessive production ofT cells is related to an intrinsic T cell defect, a thymus is also required because neonatal thymectomy eliminates lymphadenopathy. Recent evidence suggests that excessive production and release of autoreactive T cells from the thymus of lpr/lpr mice might lead to downregulation of CD4 and CD8 as a "fail safe" tolerance mechanism that occurs during late thymic or post-thymic development . To test this hypothesis, T cell receptor (TCR) transgenic mice that produce large numbers of immature thymocytes recognizing the H-2Db and male H-Y antigens were backcrossed with C57BL/6-lpr/lpr mice and MRIrlpr/lpr mice. It was predicted that Db male lpr/lpr mice would produce large numbers of autoreactive T cells during early thymic development that would lead to an accelerated lymphoproliferative disease . In contrast, Db female lpr/lpr mice would produce large numbers of Db H-Y-reactive T cells, but might not develop lymphadenopathy because the male HY antigen would not be present. Unexpectedly, there was complete elimination of lymphadenopathy in both male and female TCR transgenic lpr/lpr mice. The elimination of lymphadenopathy was not due to a failure of thymic maturation since the thymus of H-2Db female lpr/lpr mice contained nearly normal numbers of mature thymocytes. Elimination of lymphadenopathy was also not due to a lack of autoreactive T cells in the peripheral lymph nodes (LN) since there was an increased syngeneic mixed lymphocyte proliferative response of LN T cells from transgenic lpr/lpr compared with +/+ mice in vitro. Hypergammaglobulinemia and autoantibody production in the transgenic lpr/lpr was present at levels comparable with or higher than control nontransgenic lpr/lpr mice, suggesting a dissociation of autoantibody production from the lymphoproliferative disease in the TCR transgenic mice. Conversely, the development of lymphadenopathy and production of CD4 -CD8 -B220+ T cells appear to be intimately linked, as both were completely eliminated in T cells expressing the transgenic TCR. We propose that lymphoproliferation and production of CD4 -CD8 -6B2+ T cells in lpr/lpr mice is related to decreased expression of the TCR, and providing the T cells with a rearranged TCR transgene overcomes this defect .
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Summary
The Ipr gene in homozygous form induces development of CD4 -CD8 -B220+ T cells and lymphadenopathy in MRL and C57BL/6 mice. Although the propensity for excessive production ofT cells is related to an intrinsic T cell defect, a thymus is also required because neonatal thymectomy eliminates lymphadenopathy. Recent evidence suggests that excessive production and release of autoreactive T cells from the thymus of lpr/lpr mice might lead to downregulation of CD4 and CD8 as a "fail safe" tolerance mechanism that occurs during late thymic or post-thymic development .
To test this hypothesis, T cell receptor (TCR) transgenic mice that produce large numbers of immature thymocytes recognizing the H-2Db and male H-Y antigens were backcrossed with C57BL/6-lpr/lpr mice and MRIrlpr/lpr mice. It was predicted that Db male lpr/lpr mice would produce large numbers of autoreactive T cells during early thymic development that would lead to an accelerated lymphoproliferative disease . In contrast, Db female lpr/lpr mice would produce large numbers of Db H-Y-reactive T cells, but might not develop lymphadenopathy because the male HY antigen would not be present. Unexpectedly, there was complete elimination of lymphadenopathy in both male and female TCR transgenic lpr/lpr mice. The elimination of lymphadenopathy was not due to a failure of thymic maturation since the thymus of H-2Db female lpr/lpr mice contained nearly normal numbers of mature thymocytes. Elimination of lymphadenopathy was also not due to a lack of autoreactive T cells in the peripheral lymph nodes (LN) since there was an increased syngeneic mixed lymphocyte proliferative response of LN T cells from transgenic lpr/lpr compared with +/+ mice in vitro. Hypergammaglobulinemia and autoantibody production in the transgenic lpr/lpr was present at levels comparable with or higher than control nontransgenic lpr/lpr mice, suggesting a dissociation of autoantibody production from the lymphoproliferative disease in the TCR transgenic mice. Conversely, the development of lymphadenopathy and production of CD4 -CD8 -B220+ T cells appear to be intimately linked, as both were completely eliminated in T cells expressing the transgenic TCR. We propose that lymphoproliferation and production of CD4 -CD8 -6B2+ T cells in lpr/lpr mice is related to decreased expression of the TCR, and providing the T cells with a rearranged TCR transgene overcomes this defect .
MRlrlpr/lpr mice have been used as a model for human ,j,~/~a utoimmune disease because they develop hypergammaglobulinemia, anti-DNA, anti-Sm, RF, and circulating immune complexes, as well as arthritis and glomerulonephritis (1) (2) (3) (4) . A striking feature of this autoimmune disease is the development of peripheral lymphadenopathy due to the expansion of an unusual T cell subset that expresses the phenotype Thy-1+, dull Ly-1, CD4 -, CD8 -, 9F3+, B220+, F23.1+, and IIr2R (5-7). Only 5% of peripheral LN T cells from Ipr/Ipr mice are cycling, suggesting that increased proliferation does not totally account for the lymphadenopathy (8) . During the first 2 wk of life, thymectomy reduces the disease, suggesting that excess numbers of abnormal cells leave the thymus and seed the periphery during this time (9, 10) . However, there does not appear to be a global defect in thymic tolerance induction because clonal deletion of certain selfreactive (Mls, I-E reactive) T cells has been observed in lpr/lpr mice (11) (12) (13) .
The present experiments were designed to directly study if overproduction of self-reactive T cells in the thymus leads to development of lymphadenopathy and excess numbers of CD4 -CDS -11220+ LN T cells . To address this question, MRLlpr/lpr and C57BL/6-lpr/lpr mice were backcrossed to a transgenic mouse expressing a TCR specific for the male H-Y antigen presented in association with MHC H-21)6 (14) (15) (16) . The rationale for using this transgenic mouse is that it allows for production of essentially a monoclonal population ofthymocyte precursor cells that are autoreactive in male but not female mice. The nonautoimmune transgenic mouse expressing the Db-restricted anti-HY TCR has been used as a model for the study of positive and negative selection in the thymus ofnormal mice (17, 18) . The transgenic TCR uses the V08.2 TCR gene product which can be identified using an antiV#8 or anticlonotypic antibody, and therefore could easily be studied during thymic development by flow rytometry analysis (17) . Previously, it has been shown that interaction of CD4+8+ thymocytes with H-2D6 molecules on thymic epithelial cells results in positive selection of CD8+ T cells expressing both the a and /3 chain of the transgenic TCR. Transgenic female mice do not produce the HY antigen, and therefore, the CD8+ T cells expressing the transgenic TCR are not self-reactive and are not subjected to a negative selection process. Transgenic males produce the H-Y antigen and the autoreactive CD8+ T cells lose the ability to be stimulated by the HY antigen by downregulation of CD8 (14) (15) (16) . Although nearly all thymocytes express the transgenic /3 chain, some thymocytes express the endogenous TCR a chain . Interaction of CD4+8+ thymocytes that rearrange and express the endogenous TCR a chain mature into CD4+ thymocytes (15) or fail to undergo positive selection and die in the thymus (16) .
The breeding of the transgenic mouse with MRl rlpr/lpr mice resulted in 16 genetically distinct groups o£mice (differing in transgene, lpr gene, sex, and MHC) for analysis. The most dramatic effect of the TCR transgene was the complete inhibition of lymphadenopathy and production of CD4 -CD8 -B220+ LN T cells in TCR transgenic mice homozygous for the lpr/lpr gene. This occurred in both male and female mice and occurred in H-2Dbib, H-2Dbik, and H-2Dkik transgenic mice. There were no detectable CD4 -CD8 -B220+ T cells in the LN of transgenic lpr/lpr mice, while nontransgenic lpr/lpr litter mates developed massive accumulation of these abnormal T cells as expected for lpr/lpr mice. The combined effect of the TCR transgene and lpr/lpr gene provides new insights into the nature of the lymphoproliferation disease in lpr/lpr mice.
Materials and Methods
Animals. The TCR transgenic male mice carrying the rearranged TCR a and 0 chains were produced as previously described (14) (15) (16) . The original breeding pairs of MRL1pr/lpr, MRL +/+ mice, C57BL/6-lpr/lpr, and C57BL/6 +/+ mice were obtained from The Jackson Laboratory (Bar Harbor, ME) .
Isolation o, f Tail DNA . A 1-cm section of tail from 4-wk-old mice was first minced into fine pieces, and then crushed by 10 strokes of a glass Dounce homogenizer in 0.9 cc of TEN buffer (50 mM Tris, pH 7.4, 50 mM EDTA, 100 mM NaCl) . After addition of 1806 50 pl ofproteinase K (100 wg/ml final concentration) (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 50 /Al of10% SDS, the sample was incubated at 50°C for 18 h with gentle rocking. If the sample was adequately digested, boiled RNase A (100 FAg/ml final concentration) (Boehringer Mannheim Biochemicals) was added and the sample was then incubated at 37°C for an additional 2 h. The DNA was gently extracted with phenol (pH 7), phenol/chloroform (1:1 vol/vol), and chloroform. After each extraction, the sample was centrifuged for 10 min in a microcentrifuge and the supemate transferred using a pipette with a cut tip. After addition of 2 vol ofethanol and gentle mixing, the DNA was precipitated bycentrifugation for 10 min at high speed, washed with 70% ethanol, and dried in a speed vac. The dried DNA was resuspended in 50 ul of TE (10 mM Tris, pH 7.4, 1 mM EDTA). The procedure yields 20-100 wg of DNA.
Southern Blots. Southern blots were prepared as previously described (7) by digestion of 10 pg of DNA with PvuII restriction endonuclease, electrophoresis, and blotting . Membranes (Nitroplus 2000; Micron Separations, Inc., Westboro, MA) were baked for 2 h at 80°C in a vacuum oven. Membranes were prehybridized and then hybridized with 1-3 x 106 cpm/ml of hybridization solution containing different DNA probes that had been labeled with 32 P-dCTP by random priming (19) to a specific activity of 109 cpm/hg. Filters were then washed with 2x SSC + 0.1% SDS at room temperature for 30 min, with 2x SSC + 0.1% SDS at 42°C for 30 min, and then with 0.1x SSC + 0.1% SDS at 60°C for 30 min; theywere then exposed to Kodak XAR-2 film (Eastman Kodak Co., Rochester, NY) at -70°C with intensifying screens for 4 d. Flow Cytometry Analysis. Single cell suspension ofthymocytes (106 per sample) were stained in PBS with 5% FCS and 0.1% sodium azide with optimal concentrations of antibodies. Incubations were for 30 min at 4°C. First-step reagents were biotin-conjugated anti-CD4 and arsynilic acid (ARS)I-conjugated (23) anti-CD8. Second-step reagents were a PE-conjugated rat IgG monoclonal (6.21 .G.11) anti-ARS, a Texas red®-PE tandem fluorochrome conjugated to streptavidin (Southern Biotechnology Associates, Birmingham, AL), and FITC-conjugated anti-Vo8 mAbs. Viable cells (10,000 per sample) were analyzed by flow rytometry on a FACSScan (Becton Dickinson & Co.) with logarithmic scales .
Cell Proliferation Assay. Spleen cells (106) from 10-wk-old mice were cultured in the presence of20 U/ml IL2 (Amgen Biological, Thousand Oaks, CA) in 200 p.l total volume. Proliferation was determined after 5 d by a 6-h pulse of 1 /ACi [3H]thymidine (Amersham Corp., Arlington Heights, IL), and [3H]thymidine uptake was measured by liquid scintillation counting.
Serum Ig Determinations. Sera was collected by retro-orbital sinus puncture from 10-wk-old mice. IgG1 and IgG2a concentrations were determined by ELISA as previously described (24) . Briefly, 96-well microtiter plates were coated with isotype-specific goat anti-mouse Ig (4 pg/ml) (Southern Biotechnology Associates) . The plates were blocked with borate-buffered saline (BBS ; 25 mM borate, 140 mM NaCl, pH 7.4)containing 1% BSA (Sigma Chemical Co., St. Louis, MO). Sera were diluted 100,000-fold with BBS containing 1% BSA and assayed after incubation for 4 h at 22°C. After each incubation, the plates were washed extensively with BBS. Bound antibodies were detected with isotype-specific alkaline phosphatase-conjugated goat anti-mouse Ig (Southern Biotechnology Associates) using p-nitrophenylphosphate (Sigma Chemical Co.) as a substrate. Ig isotype standards (Zymed Laboratories, Inc ., South San Francisco, CA) were assayed in each experiment and the absorbance at 405 nm for sera and standards were determined on a Titertek Multiskan microplate reader (Flow Laboratories, Inc., McLean, VA) .
Rheumatoid Factor and Anti-DNA Determinations. RF was determined as described above except that the %-well microtiter plates were coated with affinity-purified rabbit IgG (4 ug/ml; Sigma Chemical Co.) and sera were initially diluted 200-fold. Bound antibodies were detected with alkaline phosphatase-conjugated isotypec goat anti-mouse IgG2a (Southern Biotechnology Associates) usingp-nitrophenylphosphate (Sigma Chemical Co.) as a substrate. RF levels were expressed as the absorbance at 405 nm (A4os) . Anti dsDNA antibodies were determined as described above except that the 96-well microtiter plates were precoated with poly->.-lysine (Sigma Chemical Co.) and subsequently with dsDNA (Sigma Chemical Co.). Control poly-L-lysine-precoated wells were coated with poly-L-glutamic acid. Sera were initially diluted 200-fold and bound anti-dsDNA antibodies, expressed as Aos, were determined as described above for RF.
Results
Unambiguous Identification ofHomozygous lprllpr TCR Transgenic Mice. The 1pr (lymphoproliferation) gene is unmapped and the 1pr gene product is unknown. Therefore, the only way to identify the presence of the 1pr gene is by observation of the development of the characteristic lymphadenopathy, Figure 1 . Mating scheme used to backcross TCR transgenic mice with lpr/Ipr mice to produce TCR transgenic lprllprmice. All mice Tr -50% (+/+, Ipr/+) nl LN from the first backcross (BCI) were heterozygous for the 1pr gene and did not develop lymphadenopathy, indicated as nl LN in the figure. Transgenic mice from this generation (50% of the mice) werebackcrossed again with lpr/Ipr mice. Although 25% of the offspring mice should have inherited the transgene and should also have been homozygous for the 1pr gene (shown in the rectangular box), none of the transgenic mice developed lymphadenopathy. Apprcovmately 50% of the mice from this mating (BC2) were transgenic and these mice weremated in separate cages with lprllpr mice. Approximately 50% of the offspring were transgenic and 50% were nontransgenic. The nontransgenic mice from this generation (BC3) were evaluated as described in Table 2 for development of lymphadenopathy and 13220+ T cells. If the BC2 parent was heterozygous for the 1pr gene, -50% of the nontransgenic offspring developed lymphadenopathy, whereas if the BC2 parent was homozygous for the 1pr gene, all of the nontransgenic offspring of this mating developed lymphadenopathy and 13220+ T cells. and an increase in CD4 -CD8 -13220+ T cells in mice that are homozygous for the 1pr gene (2, 3, 5) . In addition, development of elevated serum levels of Igs of the IgG1, IgG2a, IgG2b, and IgG3 isotype occurs by 6 wk of age in lprllpr mice (4) . However, use ofthese phenotypic features to identify TCR transgenic lprllpr mice might be misleading because the presence of the transgenic TCR might alter the phenotypic characteristics of lprllpr mice. Therefore, a breeding scheme was devised that identified TCR transgenic mice that were homozygous for the 1pr gene by analysis of their nontransgenic ofprings (Fig. 1) . TCR transgenic mice were backcrossed with MRIrlprllpr mice to produce (C57BL x MRIr lprllpr)F3 mice indicated as BCt (Fig. 1 ). Approximately 50% of the BCt mice were transgenic (Tr+) and -50% were nontransgenic (Tr -). All of the mice were heterozygous for the 1pr gene (Ipr/+) . Also, 50%p of the genetic composition of these mice are from the MRL strain (50% MRL). Transgenic (C57BL x MRIrlpr/+)Fi mice were identified by Southern blot analysis of PvuIl-digested tail DNA hybridized with a probe for Va3 and Js2 (Fig. 2) . The TCR-ol and -# chain transgenes integrated at the same locus in the transgenic mice and therefore are nearly always inherited together as shown in Fig. 2 . Transgenic BC3 mice were backcrossed again with MRIrlpr/lpr mice resulting in transgenic and nontransgenic MR rlpr/lpr and MRIrlpr/+ mice ( Fig.  1 ). An identical breeding scheme was followed to produce transgenic C57BL/6-1pr/lpr mice. Surprisingly, although massive lymphadenopathy developed in apprpximately halfof the nontransgenic mice (five of nine MRL Tr-; three of six C57BL/6 Tr-), none of the TCR transgenic litter mates developed lymphadenopathy (Table 1) . Likewise, the same nontransgenic mice that developed lymphadenopathy also exhibited high levels of circulating CD4 -CD8 -13220+ T cells, whereas none of the transgenic mice developed CD4 -CD8 -B220+ T cells. Serum levels of IgG2a anti-dsDNA antibodies were elevated in transgenic MRL mice T36, T41, and T44 and transgenic C57BL/6 mice T52 and T57, but were nearly absent in other transgenic mice ( Table 1 ). The elevated levels of anti-dsDNA autoantibodies correlated with higher IgG2a RF production and serum Ig levels in transgenic MRL 1 Figure 2 . Identification of TCRtransgenic mice by analysis of tail DNA. 10 ug of tail DNA from backcrossed mice was digested with PvuII restriction enzyme and analyzed by Southern blot analysis with probes for Va3 and J02 which hybridize to both transgenic and endogenous DNA. The Va3 probe hybridized to a 6.0-kb endogenous band in all mice, but also to transgenic DNA bands at 9.0, 7.0, and 5.0 kb. The J02 probe hybridized to a 5.5-kb endogenous band in all mice, but also to a transgenic DNA band at 7.7 kb. The eartag number of transgenic mice is shown above the figures.
BCC (50% MRL
' Transgenic (T) and nontransgenic (NT) mice were evaluated at 14-16 wk of age. Transgenic and nontransgenic C57BL/6 mice were evaluated at 16-18 wk of age. Results of analysis of transgenic mice are listed separately. Results of analysis of nontransgenic littermate mice are presented for comparison . The data from different groups of nontransgenic mice (differing in lpr and sex) were combined to determine the mean. n, number of mice . Offspring data from 5 individual transgenic 2nd backcross parent mice after mating with MRL-lpr/lpr or C57BL/6-lpr/lpr mice. Offspring of MRL mice were evaluated at 14-16 wk of age and offspring of C57BL/6-lpr/lpr mice were evaluated at 16-18 wk of age . t Results of the analysis of offsprings from single parent were grouped according to presence of the transgene or sex . Approximately 50% ofoffspring mice expressed both the TCR-a and -0 chain which were always inherited together in these mating . n, number of mice per group. s LN weight, percent B220+ T cells, anti-dsDNA, RF, and serum Ig levels were determined as in Table 1 . The number of mice with elevated values for each parameter was defined as being 2 SD above the mean, for age, sex, and strain-matched nontransgenic Ipr/ + heterozygous mice. and C57BL/6 mice ( Table 1) . Although the autoantibody and Ig data suggested that the lpr gene was present in homozygous form in -50% of the transgenic mice, the absence of lymphadenopathy and CD4 -CD8 -B220+ T cells was unusual and necessitated further breeding analysis .
To clearly document the existence of TCR transgenic lpr/lpr mice, parents T36, T37, T44, T50, and T52 were placed in separate cages, and backcrossed again with MRLlprllpr or, for T52, with C57BL/6-lpr/lpr mice (Fig. 1) . The presence ofthe lpr gene in homozygous form in the parents could then be verified after assessment of their nontransgenic offspring for development of lymphadenopathy, CD4 -CD8 -B220+ T cells, and autoantibodies . Analysis of mice from this third backcross confirmed that T36, T44, and T52 parental mice were homozygous for the lpr gene and T37 and T50 parental mice were heterozygous for the lpr gene ( Table 2 ). All nontransgenic offspring of T36, T44, and T52 parents developed 1809 Mountz et al.
lymphadenopathy, elevated anti-DNA and RF titers, and elevated serum levels of Ig (Table 2 ). Approximately 50% of the nontransgenic offsprings of T37 and T50 developed lymphadenopathy, elevated anti-DNA, and elevated RF as expected if the TCR transgenic parents were heterozygous for the lpr gene. Thus, although none ofthe transgenic parents developed lymphadenopathy, the presence of the lpr gene in homozygous form could be detected by analysis of transgenic negative offspring . Serum levels of anti-dsDNA were not effected by the presence of the transgene, but were positive in 70-80% oflpr/Ipr mice as expected for 10-14-wk-old mice. Serum levels of RF and Igs were higher in transgenic C57BL/6-lpr/lpr backcross mice. All transgenic mice and controls used for analysis in this study were genetically at least 87.5% MRL or 87.5% C57BL/6 and will be referred to as MRL or C57BL/6, respectively. The development oflymphadenopathy, without exception, in 100% (47 mice) of non- (3) . This would predict that Db-expressing transgenic male mice would have increased lymphadenopathy compared with Db-expressing female mice or with Dk-expressing male or female mice. Alternatively, lymphadenopathy has been proposed to result from an intrinsic T cell growth abnormally unrelated to the TCR specificity (25) (26) . This would predict that replacement of endogenous TCR gene expression with expression of a transgenic TCR gene would have no effect on the intrinsic growth abnormality and lymphadenopathy in MRIrlpr/Ipr mice.
Therefore, the effect of sex and H-2 on development of lymphadenopathy and on development of the CD4 -CD8 -B220+ T cells was examined in TCR transgenic mice (Table  3) . Unexpectedly, neither male nor female TCR transgenic mice developed lymphadenopathy, regardless of expression of Dk or Db in the thymus or LN of these mice. Nontransgenic lpr/lpr litter mates developed enlarged LN as expected (Table 3) . Therefore, the presence of the Db-restricted H-Y-reactive transgenic TCR resulted in elimination of lymphadenopathy independent of expression of the Db and male H-Y antigen, suggesting the specificity of the transgenic TCR was not playing a critical role in the reduction oflymphadenopathy.
Reduction in Dull Thri, B220+ T Cells in the Thymus and LN ofTCR Transgenic MRI Ipr/lpr Mice. To determine the effect of the TCR transgene on production of the abnormal T cells in MRIrlpr/lpr and C57BL/6-Ipr/Ipr mice, simultaneous ' Data from 100 mice divided into 20 groups of mice differing in strain (MRL = 87 .5% MRL/Mpj; C57BL/6 = 87 .5% C57BL/6J), transgene expression, H-2 (b/k = H-2bik ; k/k -H-2k/k ; b/b = H-2b/b), and sex (M = male, F = female) . t n, number of mice in each group. S LN weight and the percent of Thy 1+,B220+ cells (B220+ T cells) were determined as in Table 1 . The total number of thymocytes was determined on each mouse after sacrifice and preparation of thymocyte cell suspensions.
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T Cell Receptor Transgene Prevents Lymphadenopathy in lpr/lpr Mice 6B2-6B2 - Figure 4 . Expression of Thy 1, CD4, and B220 on thymocytes from nontransgenic and TCR transgenic H-26ik female MR1r1pr/lpr mice. Flow cytometry analysis was carried out as described for Fig. 3 .
dull (gate B) or Thy-1 bright (gate C) (Fig. 3, top) . In nontransgenic MR1Jlpr/lpr mice, the Thy-1-negative population of LN cells was B220+CD4 -CD8 -as expected for B cells (Fig. 3, A) . The dull Thy-1 population was predominantly abnormal B220+ T cells but also contained some B220+CD4+ T cells (13, 27) (Fig. 3, B) . In TCR transgenic MRIrlpr/Ipr mice, the intensity profile of Thy-1 on LN T cells had an increase in Thy-l-negative and bright Thy-1 lymphocytes, and a decrease in dull Thy-1 lymphocytes. an increased percentage of mature bright Thy-1 CD4+ or CD4' T cells (Fig. 3, A-C) . It is possible that abnormal B220+ T cells could be present in the thymus of TCR transgenic MR1r1pr/lpr mice as reported for nontransgenic MRIrlpr/lpr mice, but not be detected in peripheral lymphoid organs . The histogram of Thy-1 for nontransgenic MRLIpr/1pr thymocytes revealed a small dull Thy-1 population (Fig. 4, top) . These were not due to contaminating encroaching LN because histologic sections of this thymus demonstrated the presence of B220+ cells within the thymus and the absence of perithymic lymphoid tissue (28) (data not shown) . The Thy-l-negative thymocytes were predominantly B220+ . This is consistent with previous reports of B cells within the thymus of autoimmune strains of mice (29) . The dull Thy-1 population contained substantial numbers of B220+ T cells, and also B220 -normal thymocytes, which were predominantly CD4+ (CD4+,CD8+) . Only normal thymocytes were found in the bright Thy-1 population (Fig. 4, C) . TCR transgenic MR1rlpr/1pr mice contained predominantly a single bright Thy-1 population of thymocytes (Fig. 4, top) . The Thy-1-negative population is B220+ and indistinguishable from B cells found in the LN, suggesting that the transgene does not result in a reduction of B cells in the thymus of MRIrlpr/lpr mice. Less than 1% of the dull Thy-1 population of thymocytes were B220+ T cells. Bright Thy-1 thymocytes in transgenic MRIrlpr/1pr mice contained no B220+ thymocytes. In addition, there were increased numbers of CD4 -B220 -bright Thy-1 thymocytes . These results suggest that the transgene greatly reduces or eliminates development of the dull Thy-1 B220+ T cells in the LN, and thymus of MR1rlpr/lpr mice. The percent of B220+Thy 1+ abnormal T cells in LN of lprllpr, and +/+ mice differing in strain, transgene expression, H-2, and sex is summarized in Table 3 .
Reduction ofLymphadenopathy Is Not Due to Lack of T Cell Maturation in the Thymus. The cellular basis underlying development of lymphadenopathy in lprllpr mice has been proposed to be due to release of excessive numbers of autoreactive T cells from the thymus to the LN (2, 3) . One possible explanation for a decrease in lymphadenopathy would be that the TCR transgenic lpr/lpr mice may have a decrease in production of mature thymocytes leading to a decrease in lymphadenopathy. This effect might be especially important in H-2Db-expressing male mice, because the majority of thymocytes express the transgenic TCR and therefore these self-reactive T cells could be eliminated in the thymus by a negative selection process. To investigate the overall effect of the TCR transgene on thymocyte development, the total number of thymocytes was determined in 20 groups ofmice differing in strain, transgene expression, H-2, and sex (Table 3) . There was an increase in the number of total thymocytes in nontransgenic MRlrlpr/lpr and C57BL/6-1pr/lpr mice compared with nontransgenic MRL +/+ and C57BL/6 +/+ mice as previously described (28) . There were high numbers of thymocytes in both transgenic MRlrlpr/lpr and MRL +/+ Dbik female mice. This is consistent with the presence of a high rate of positive selection on Db thymic epithelial cells, and also a low rate of negative selection due to the absence of the male antigen . In contrast, there is a dramatic decrease in the total number of thymocytes in transgenic MRL +/+ Db/k male mice to 15% of that observed in a normal thymus consistent with a high rate of positive selection and also a high rate of negative selection due to the presence of the male H-Y antigen. However, in transgenic MRIrlpr/lpr Db/k male mice, there was only a 50% decrease in the total number of thymocytes, compared with nontransgenic MR1r1pr/lpr mice or transgenic Db/k female MRIrlpr/lpr mice . This suggests that selection events in the thymus of MRlrlpr/lpr mice are significantly altered compared to MRL +/+ mice. The thymus of Dk/k male and female transgenic mice are reduced to between one third and one half of normal size. This is consistent with the lack of efficient positive and negative selection of transgene-expressing T cells on Dk1k thymic cells. In transgenic C57BL/6-lpr/lpr and C57BL/6 +/+ female mice, there were nearly normal numbers of thymocytes as described above for MRL Db/k female mice. There was a dramatic reduction in total numbers of thymocytes in transgenic C57BL/6-lpr/lpr and C57BL/6 +/+ male mice. However, there was a twofold increase in the number of thymocytes in transgenic C57BL/6-lpr/lpr males compared with transgenic C57BL/6 +/+ males, again suggesting an altered selection process in lprllpr mice compared with +/+ mice. These data indicate that although the H-2Db-expressing TCR transgenic lprllpr male mice have a decrease in number of thymocytes, these were increased in numbers compared with male +/+ mice . Also, transgenic Dbnb and Dblk female mice had normal numbers of thymocytes compared with nontransgenic mice. Therefore, elimination of lymphadenopathy in female lprllpr mice could not be solely attributed to negative selection in the thymus .
T Cellsfrom LNofTCR Transgenic lpr/1prMice Can Proliferate In Vitra Development of lymphadenopathy in lprllpr mice has been proposed to result from proliferation of self-reactive Figure 5 . SMLR proliferative response to transgenic and nontransgenic lprllpr and lpr/+ mice. Spleen cells (106) were cultured for 5 d at 37°C in 5% C02 . During the last 6 h of culture, 1 yCi [3H]thymidine was added and proliferation was measured as [3H]thymidine uptake. The value shown is the mean ± SEM for the average of triplicate cultures performed using 2-4 individual mice per group. H-2k/k and H-2eik mice were from the MRL strain . H-2b/b mice were from the C57BL/6 strain .
T Cell Receptor Transgene Prevents Lymphadenopathy in lprllpr Mice
T cells present in vivo (30) (31) (32) (33) (34) . One possible explanation for the inhibition of lymphadenopathy in the TCR transgenic Ipr/lpr mice might be that there was a loss of self-reactive LN T cells in TCR transgenic mice. Although early, high expression of the transgenic TCR is known to occur in the thymus (16), these cells might be efficiently eliminated by negative selection in the thymus in both +/+ and lprllpr mice expressing the Db and H-Y antigen . Alternatively, in lprllpr mice not expressing the Db and H-Y antigen, production oflarge numbers ofmature T cells expressing the transgenic TCR might inhibit production of T cells capable of reacting with self. Therefore, to determine ifLN T cells from TCR transgenic lprllpr mice contain cells capable of selfstimulation, syngeneic mixed lymphocyte reaction (SMLR) analyses were performed (Fig. 5 ). There was a dramatic increase in the SMLR proliferative potential of T cells from TCR transgenic C57BL/6-Ipr/Ipr male and female Db/b mice compared to TCR transgenic C57BL/6-Ipr/+ mice. These results suggest that autoreactive T cells are present in the LN ofC57BL/6-Ipr/Ipr mice. There was no significant change in the SMLR proliferative potential of T cells from TCR transgenic MRLIpr/Ipr male or female Dk/k or Db/k mice compared with control TCR transgenic MRLIpr/+ mice or nontransgenic mice. This was not simply due to the absence of Db/b male stimulator cells because there was also no significant difference in the proliferative responses of T cells from these mice after culture with irradiated Db/b male stimulator cells (data not shown) . Therefore, although it could be argued that in lprllpr Dk1k and DI/k mice, lymphadenopathy is eliminated because there is no self-stimulation, this is not true for C57B1/6-Ipr/Ipr mice as there were numerous T cells capable of responding in vitro to self-antigen. These data also suggest that a suppression mechanism is present in C57BL/6-lpr/lpr mice in vivo that is released by in vitro culture. Elevated Autoantibody and Ig Production Occur Independently of Lymphadenopathy. The presence of the TCR transgene completely inhibited the lymphadenopathy and the development of CD4 -CD8 -B220+ T cells in lprllpr mice. However, the data from the lpr1lpr and lpr1+ backcross mice suggested that the transgenic lprllpr mice still developed elevated levels of anti-DNA autoantibodies, RF, and Ig (Tables 1 and  2 ). To determine the effects of the TCR transgene on autoantibody production, and to verify that autoantibody production and hypergammaglobulinemia could be dissociated from lymphadenopathy, serum antibody levels in TCR transgenic lprllpr mice were compared with nontransgenic lprllpr mice (Table 4 ). There was no significant difference in serum levels of IgM and IgG2a anti-dsDNA antibodies in TCR transgenic MRLIpr/Ipr mice compared with nontransgenic MRL lprllpr mice. Nontransgenic C57BL/6-Ipr/Ipr mice had lower levels of IgM and IgG2a anti-dsDNA compared with nontransgenic MRLlprllpr mice as previously reported (4), but there was no difference between TCR transgenic C57BL/6-lprllpr mice and nontransgenic C57BL/6-Ipr/lpr mice.
Serum levels of IgM and IgG2a RF were elevated in 12-16-wk-old transgenic and nontransgenic MRLIpr/Ipr mice compared with transgenic and nontransgenic MRL +/+ mice 1813 Mountz et al .
( Table 4 ). There was a significant increase in the IgM RF levels in the TCR transgenic Db/k male MRL1pr/lpr mice compared with the TCR transgenic Db/k female MRL lpr/Ipr mice (p < 0.05). The higher levels of RF were not observed in the TCR transgenic H-2Dkik male mice; therefore the expression of H-2Db was also required. Serum levels of RF were elevated in 12-16-wk-old transgenic and nontransgenic C57BL/6-lpr/lpr mice compared with transgenic and nontransgenic C57BL/6 +/+ mice. There was a significant increase in IgM and IgG2a RF level in transgenic Db5 male C57BL/6-Ipr/lpr compared with nontransgenic male C57BL/6-Ipr/Ipr mice (p < 0.05). Serum levels of immunoglobulins of the IgG1 and IgG2a isotype were significantly higher in nontransgenic lpr/lpr mice compared with nontransgenic +/+ mice, consistent with previous observations (4) . The serum level of IgG1 was significantly higher in transgenic Db/b C57BL/6-Ipr/Ipr male mice compared with nontransgenic Db/b C57BL/6-Ipr/lpr male mice (p < 0.05). These results indicate that although the transgene resulted in the elimination of lymphadenopathy and formation of CD4 -CD8 -B220+ T cells, high levels of anti-DNA, RF, and Ig's persist in transgenic lprllpr mice. These results are in agreement with previous data suggesting that lymphadenopathy can be dissociated from hypergammaglobulinemia and autoantibody production in MRLIpr/lpr and C57BL/6-Ipr/Ipr mice (24, 35) . Moreover, these data also suggest that the transgene can enhance RF and Ig production in lprllpr mice in the presence of both the H-2Db antigen and the male antigen . Thus, recognition of the Db + H-Y antigen by the transgenic TCR plays a role in augmentation of RF and IgG1 production .
The cellular and molecular basis for overproduction of the CD4 -CD8 -B220+ T cells in the LN of lprllpr mice is'unknown . Neonatal thymectomy inhibits development oflym~h-adenopathy (9, 10) , and partial inhibition is evident if the mice are thymectomized before 3 wk of age (9) . This has led to the conclusion that T cells that develop in and leave the thymus during the first 3 wk of life migrate to the periphery and lead to lymphadenopathy. It has been difficult to separate the contribution of autostimulation resulting in peripheral expansion of T cells in LN of lprllpr mice from an endogenous T cell maturation defect leading to lymphadenopathy without stimulation through the TCR (25, (30) (31) (32) . The total suppression oflymphadenopathy in the TCR transgenic lprllpr mice provides further insight into this question. The presence of the TCR transgene results in early, high levels of expression ofthe TCR in thymocytes (16) . The transgenic TCR that recognizes H-2Db and the male HY antigen is expressed on nearly 100% ofimmature thymocytes. Therefore, in H-2Db male lpr/lpr mice, there is production of large numbers ofimmature thymocytes which are autoreactive. In H-2k/k or female lprllpr mice, the TCR is not autoreactive .
Also in H-2Db mice, there is a high probability that the TCR transgene-expressing T cells will undergo positive selection whereas in Dk/k mice, positive selection of transgenic 
TCRexpressing T cells is a rare event (18) . Despite these different positive and negative selection events that occur in the lprllpr strains of mice studied, none of the transgenic mice developed lymphadenopathy or detectable numbers of CD4 -CD8 -B220+ T cells . Therefore, we propose that the presence of early, high expression of the transgenic TCR, independent ofspecificity or thymic selection, leads to elimination oflymphadenopathy and autoimmunity. The mechanism for this will be discussed in terms oftwo different models proposed to explain the generation of CD4 -CD8 -B220+ T cells in lprllpr mice. The first model for generation of CD4 -CD8'B220 + T cells suggests that an abnormal positive selection process in the thymus of the lprllpr mice results in massive lymphadenopathy (36) . The data presented herein support and shed new light onto this model. The observation that T cells expressing self-reactive (Mls or MHC-reactive) V,6 regions are deleted from the CD4 -CD8 -B220+ LN T cells (11) (12) (13) and also from both the CD4+ and CD8+ single positive LN T cells in lprllpr mice (36) led to the suggestion that the CD4 -CD8 -B220+ T cells are derived from a CD4+CD8+ precursor by abnormal positive selection (36) . We have recently observed that in H-2Db-and HYreactive TCR transgenic mice, there is an overefficient positive selection process in lprllpr mice compared to +/+ mice resulting in depletion of the CD4+CD8+ thymocytes subpopulation and expansion of CD4+ and CD8 + single-positive thymocytes. (T Zhou, H. Bluthmann, and J. D. Mountz, manuscript in preparation) . This aberrant positive selection has been proposed to result in active downregulation of CD4 and CD8 and production of CD4 -CD8' T cells which leave the thymus and migrate to the periphery (11) (12) (13) 36) . Furthermore, since these CD4 -CD8 -T cells are the result of a positive selection process, they would be expected to be skewed towards reactivity with MHC, as observed in lprllpr mice (30) (31) (32) . The mechanism behind the proposed aberrant positive selection in the thymus of lprllpr mice is not known, but may be related to a maturational defect resulting in low expression of TCR and CD3 as observed on the CD4 -CD8 -B220+ in the LN of lprllpr mice (37) . The presence of the TCR transgene might overcome this maturational defect by allowing the cells to express high levels of the TCR and CD3 . This would also suggest that a defect of TCR expression might represent an intrinsic thymic maturational abnormality of T cells in lprllpr mice.
The second model for generation of CD4 -CD8 -B220+ T cells suggest that an intrinsic T cell defect, which may require the lprllpr internal milieu, results in massive lymphadenopathy (25, 26) . This model is not supported by the demonstration that a transgenic TCR can eliminate lymphadenopathy. A number ofdefects have been identified in lprllpr mice including abnormal phosphorylation of the tyrosine residues of membrane proteins (38) , rapid TCR and CD3 modulation (39) , altered K+ channel expression (40) , aberrant arachidonic acid turnover in T cell membranes (41) , and enhanced or altered regulation of c-myb, c-raf, and c-my~on-cogenes (42) . The mechanism by which one or more ofthese defects could lead to production of CD4 -CD8 -B220+ T cells is not known, but all of these defects have been related to altered states of T cell activation. For example, phosphor), lation of the TCR/CD3-t chain is associated with T cell activation, and constitutive phosphorylation might be an aberration of this process . The transgenic TCR would induce early high levels of TCR expression in the thymus of lprllpr mice. It is unlikely that TCR transgene expression could directly reverse a primary defect in any of the metabolic pathways which have been associated with the CD4 -CD8 -B220+ T cells of lpr mice. It is possible, but still unlikely, that the rearranged TCR transgene and early TCR expression could indirectly inhibit one of these metabolic events. For example, if constitutive phosphorylation of the TCR/ CD3-r chain was a fundamental defect leading to lymphoproliferation (37) , this defect should still be present despite the presence of a rearranged TCR transgene . Therefore, we conclude that the metabolic defects described above result from a more fundamental T cell maturation abnormality that can be corrected in the TCR transgenic mice. A note ofcaution is required in this interpretation because these previously described metabolic abnormalities have not yet been measured in the LN T cells of TCR transgenic lprllpr mice.
Several treatment schemes have been used to reduce the lymphoproliferative disease and autoimmune disease in MRls lprllpr mice. Treatment with cyclophosphamide affected both B cell and T cell development resulting in reduction oflymphadenopathy, autoantibody production, and autoimmune disease (43) . Treatment with cyclosporine A reduced lymphadenopathy and autoimmunity by interfering with T cell signaling, but did not reduce autoantibody production (24) . Treatment with Mel 14 prevented lymphadenopathy by blocking peripheral LN homing ofT cells, but did not reduce autoantibodies (35) . In the present study, the presence of a rearranged transgenic TCR gene completely inhibited development of lymphadenopathy and formation of CD4 -CD8-B220+ cells in 1pr11pr mice. In H-2k/k mice, there was no significant difference in hypergammaglobulinemia or autoantibody production between transgenic and nontransgenic lprllpr mice. In male H-2b/k and H-Vb lprllpr mice, there was an increase in Ig and RF production compared with nontransgenic lprllpr mice. These results support previous findings that the lymphoproliferation disease and autoantibody production in lprllpr mice can be dissociated .
